Clinical Trial Update: A Study of MCARH109 and MCARH125 in People With Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update on MCARH109 and MCARH125 in people with multiple myeloma, including refractory and relapsed disease, currently listed as active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Relapse Multiple Myeloma

Drugs mentioned

• MCARH109
• MCARH125

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 | Status: ACTIVE_NOT_RECRUITING